科华生物：2025年半年度公司实现营业收入793574870.31元

Group 1 - The core point of the article is that Kehua Bio reported a decline in revenue and a net loss for the first half of 2025, indicating financial challenges for the company [1] Group 2 - For the first half of 2025, the company achieved operating revenue of 793,574,870.31 yuan, which represents a year-on-year decrease of 12.65% [1] - The net profit attributable to shareholders of the listed company was -133,452,683.41 yuan, indicating a significant loss [1]